David A Becker

Suggest Changes
Learn More
OBJECTIVE The objective of this study was to report the tolerability and toxicity of a regimen consisting of intravenous (IV) docetaxel and intraperitoneal (IP) cisplatin and paclitaxel with(More)
  • 1